← All datasets

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for amyotrophic lateral sclerosis and frontotemporal dementia

Organism: Mus musculus
Platform: GPL11154
Samples: 33
Experiment Types:
Expression profiling by high throughput sequencing
Submitted: Oct 25 2013
Last Updated: May 15 2019
Status: Public on Nov 12 2013
Contact: John,,Ravits (UCSD)

Relations

SuperSeries of: GSE51684 SuperSeries of: GSE51685 BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA224742

Summary

This SuperSeries is composed of the SubSeries listed below.

Overall Design

Refer to individual Series

Analysis (4 steps)

View Data Processing
Processing steps for GSE51741
  1. Illumina Casava1.8.2 software used for basecalling.
  2. Demultiplexing based on index sequences
  3. Sequenced reads were mapped to Refseq RNA sequences using bowtie v0.12.7 with parameters -q -e 100 -m 10 --best --strata
  4. Count reads for each genes
GEO Samples (33)

Dataset Citations (1)

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
PMID 24170860 · 2013 · Proceedings of the National Academy of Sciences of the United States of America
Clotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, Shuying Sun, Patrick Liu, Hai-Ri Li, Jie Jiang, Andrew T Watt, Seung Chun, Melanie Katz, Jinsong Qiu, Ying Sun, Shuo-Chien Ling, Qiang Zhu, Magdalini Polymenidou, Kevin Drenner, Jonathan W Artates, Melissa McAlonis-Downes, Sebastian Markmiller, Kasey R Hutt, Donald P Pizzo, Janet Cady, Matthew B Harms, Robert H Baloh, Scott R Vandenberg, Gene W Yeo, Xiang-Dong Fu, C Frank Bennett, Don W Cleveland, John Ravits

Linked Publications (1)

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
Proceedings of the National Academy of Sciences of the United States of America · 2013